Stay updated on Safety and Efficacy of Sparsentan in IgA Nephropathy Clinical Trial

Sign up to get notified when there's something new on the Safety and Efficacy of Sparsentan in IgA Nephropathy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety and Efficacy of Sparsentan in IgA Nephropathy Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-10-31T23:13:59.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    A sitewide NIH notice about terminology changes during a website transition appears at the top of the study record.
    Difference
    0.8%
    Check dated 2026-10-24T23:18:45.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-17T23:35:50.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The site footer revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-10T23:33:19.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Capitalization of the 'Find contact information' label was updated to 'Find Contact Information'. A new 'Revision: v3.7.0' entry was added to the history, indicating a new page version.
    Difference
    0.2%
    Check dated 2026-09-19T22:30:33.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    The study record history now includes a new revision entry v3.6.6, replacing the previous v3.6.5 in the version list. This reflects an updated release note for the record.
    Difference
    0.1%
    Check dated 2026-08-29T20:42:31.000Z thumbnail image

Stay in the know with updates to Safety and Efficacy of Sparsentan in IgA Nephropathy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety and Efficacy of Sparsentan in IgA Nephropathy Clinical Trial page.